REFERENCES
  1. Das AK, Reddy KS, Suwanjindar P, Fulmer A, Siquiera C Jr, Floten S et al. A. Primary Tumors of the Aorta. Ann Thorac Surg 1996;62:1526-8
  2. Burke A. Tumors of the heart and great vessels. Atlas of tumor pathology 1996;16:171–9
  3. Yerebakan C, Liebold A, Steinhoff G, Skrabal CA. Papillary Fibroelastoma of the Aortic Wall With Partial Occlusion of the Right Coronary Ostium. Ann Thorac Surg 2009;87:1953–
  4. Rolf T, Iglesias JF, Tozzia P, von Segessera LK. Acute myocardial infarction caused by coronary embolization of a papillary fibroelastoma of the thoracic ascending aorta. Interactive CardioVascular and Thoracic Surgery 11 (2010) 676–678
  5. Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB. Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol 1997;30:784–90
  6. Anand S, Sydow N, Janardhanan R. Papillary fibroelastoma diagnosed through multimodality cardiac imaging: a rare tumour in an uncommon location with review of literature. BMJ Case Reports 2017(8);2017:bcr-2017-219327
  7. Gonzalez-Santos JM, Arnaiz-Garcıa ME, Vargas-Fajardo MC, Arribas-Jimenez A. Aortic wall papillary fibroelastoma J Thorac Cardiovasc Surg 2013;146:e1-3
  8. Sun JP, Asher CR, Yang XS, Cheng GG, Scalia GM, Massed AG et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation 2001;103:2687–93.
  9. Gowda RM, Khan IA, Nair CK, Metha NJ, Vasadava BC Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J 2003;146:404–10.
LEGENDS
Figure 1 . A: TEE showing a mobile, irregular mass of 1x1,5 cm diameters in right coronary sinus. B: CTA scan confirming the presence of the mass in ascending aorta
Figure 2. A: Surgical view of the mass. B: Macroscopic view of the resected mass. C: The histology shows individual fronds consisting of a core of hyalinized hypocellular stroma that is rich in elastic fibers and a lining of hyperplastic endocardial cells (magnification ratio:200:1 – 400:1. Haematoxylyn eosin staining)